Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)

HKD 13.9

(17.0%)

Eps Summary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s latest annual eps in 2023 was -0.96 CNY , up 4.0% from previous year.
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s latest quarterly eps in 2024 Q2 was -0.06 CNY , down 0.0% from previous quarter.
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd. reported an annual eps of -1.00 CNY in 2022, up 32.43% from previous year.
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd. reported an annual eps of -1.48 CNY in 2021, down -8.03% from previous year.
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd. reported a quarterly eps of -0.06 CNY for 2024 Q1, up 73.5% from previous quarter.
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd. reported a quarterly eps of N/A for 2023 FY, up 4.0% from previous quarter.

Annual Eps Chart of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2023 - 2020)

Historical Annual Eps of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2023 - 2020)

Year Eps Eps Growth
2023 -0.96 CNY 4.0%
2022 -1.00 CNY 32.43%
2021 -1.48 CNY -8.03%
2020 -1.37 CNY 0.0%

Peer Eps Comparison of Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Name Eps Eps Difference
Uni-Bio Science Group Limited 0.01 HKD 8748.649%
CK Life Sciences Int'l., (Holdings) Inc. 0.00 HKD 53433.333%